Evidence map›Paper›PMID 26251773›Full record

ArticleSpringerPlus2015

Posterior fossa ependymoblastoma diagnosed in the second month of life: uneventful 12 years survival after gross total resection followed by chemotherapy.

Bernt Johan Due-Tønnessen, Arild Egge, Tryggve Lundar, Bård Krossnes, Einar Stensvold, Paulina Due-Tønnessen, Petter Brandal

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in SpringerPlus, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bernt Johan Due-TønnessenDepartment of Neurosurgery, Oslo University Hospital, Postboks 4950, Nydalen, 0424 Oslo, Norway.
Arild EggeDepartment of Neurosurgery, Oslo University Hospital, Postboks 4950, Nydalen, 0424 Oslo, Norway.
Tryggve LundarDepartment of Neurosurgery, Oslo University Hospital, Postboks 4950, Nydalen, 0424 Oslo, Norway.
Bård KrossnesDepartment of Pathology, Oslo University Hospital, Oslo, Norway.
Einar StensvoldDepartment of Pediatrics, Oslo University Hospital, Oslo, Norway.
Paulina Due-TønnessenDepartment of Radiology, Oslo University Hospital, Oslo, Norway.
Petter BrandalDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Oslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report on an infant who underwent gross total resection (GTR) of a posterior fossa ependymoblastoma in the second month of life followed by chemotherapy with uneventful long-term survival for 12 years. Postoperative radiotherapy has been considered obligate to have a chance for prolonged survival, but is inadvisable in infants. To our knowledge, this is the first reported long-term survival in an infant treated for ependymoblastoma.

Indexed as

Long-term survivalPediatric neurosurgeryPosterior fossa ependymoblastoma

Identifiers

PMID26251773
PMCPMC4522267
OpenAlexW2105695972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.